Home      About this journal      Authors      Editors      Readers      Archive      Contact us
The effect of Xifeng Capsule combined with carbamazepine on hippocampal voltage-gated sodium channel of epilepsy rat models indused by Lithium-pilocarpine
Hits 576  Download times 317  Received:December 03, 2021  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2022.09.18
Key Words   voltage-gated sodium channel;Xifeng Capsule;carbamazepin;epilepsy
Author NameAffiliationE-mail
LU Yanli Pediatrics, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
FANG Yanyan Pediatrics, Chinese Medicine Hospita in Linyi, Linyi 276002, China  
LI Xinmin Pediatrics, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
lixinmin1998@sohu.com 
SUN Dan Pediatrics, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
HAN Yaowei Pediatrics, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
CHEN Zumin Pediatrics, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China 
 
Abstract
    [Objective] To observe the effects of Xifeng Capsule combined with carbamazepine (CBZ) on voltage-gated sodium channels (VGSC) in hippocampal neurons of epileptic SD rats induced by lithium chlorine-pilocapine.[Methods] The 20 SD rats were randomly selected from 110 SD rats as blank control group,and 80 rats were randomly selected after successful modeling,which were divided into model control group,Xifeng Capsule treatment group,Xifeng Capsule combined with CBZ treatment group,and CBZ treatment group.The expression of VGSC was detected by immunohistochemistry and its electrophysiological function was detected by whole cell patch clamp.[Results] 1) Recurrent spontaneous seizures occurred in the epileptic rats,and the frequency of seizures in the Xifeng Capsule combined with CBZ group was lower than that in the Xifeng Capsule treatment group and the CBZ group.2) Expression of VGSC:the expression level of VGSC in all treatment groups was down-regulated in CA3 region compared with that in model control group,and the expression level of VGSC in Xifeng Capsule combined with CBZ group was significantly lower than that in wind quenching group and CBZ group.3) Electrophysiological function of VGSC:compared with the model control group,the peak current in the treatment group decreased significantly,especially in the card extinguishing group compared with the Xifeng Capsule treatment group and CBZ group.The half steady-state activation voltage in the treatment group increased,but there was no difference between the groups.The 50% steady-state inactivation voltage of the treatment group decreased,and there was a difference between the Xifeng Capsule combined with CBZ group and the Xifeng Capsule treatment group.After inactivation,the recovery time constant of the treatment group was significantly prolonged,and there was a difference between the Xifeng Capsule combined with CBZ group and the Xifeng Capsule treatment group.[Conclusion] Xifeng Capsule and CBZ have synergistic antiepileptic effect.The main pharmacological mechanism superior to monotherapy is to reduce peak VGSC current.

You are the 2306056 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.